Compliance & Quality
Regulatory posture and tissue handling.
Kindr Clinical operates under U.S. federal regulations for human cells, tissues, and cellular and tissue-based products (HCT/Ps). The summary below reflects our regulatory posture. Specific claim copy is pending legal review; placeholders are clearly marked.
FDA Establishment Registration
Kindr Clinical is a U.S.-based distributor of HCT/P products. FDA establishment registration number: [EDIT ME — pending].
21 CFR Part 1271 (HCT/P) Handling
All amniotic allograft tissue products are handled in accordance with 21 CFR Part 1271, including donor eligibility, screening, and current good tissue practice (CGTP) requirements as applicable to our role in the supply chain.
Quality Standards
Standard operating procedures cover receiving, cold-chain handling where applicable, lot-level traceability, complaint handling, and recall readiness. [EDIT ME — additional certifications].
Tissue Traceability
Every shipment is traceable from manufacturer/processor lot through to the receiving practice. Lot numbers and expiration dates are documented on every order and quote.
Adverse Event Reporting
Suspected adverse reactions or product issues can be reported to our quality team at [EDIT ME — quality email]. We coordinate with manufacturers and regulators as required.
This page is informational and not a substitute for product labeling, IFUs, or your institution's policies.